306 related articles for article (PubMed ID: 36530433)
1. Blood-stage antiplasmodial activity and oocyst formation-blockage of metallo copper-cinchonine complex.
Morais CMG; Brito RMM; Weselucha-Birczyńska A; Pereira VSS; Pereira-Silva JW; Menezes A; Pessoa FAC; Kucharska M; Birczyńska-Zych M; Ríos-Velásquez CM; de Andrade-Neto VF
Front Cell Infect Microbiol; 2022; 12():1047269. PubMed ID: 36530433
[TBL] [Abstract][Full Text] [Related]
2. Novel antimalarial chloroquine- and primaquine-quinoxaline 1,4-di-N-oxide hybrids: Design, synthesis, Plasmodium life cycle stage profile, and preliminary toxicity studies.
Bonilla-Ramirez L; Rios A; Quiliano M; Ramirez-Calderon G; Beltrán-Hortelano I; Franetich JF; Corcuera L; Bordessoulles M; Vettorazzi A; López de Cerain A; Aldana I; Mazier D; Pabón A; Galiano S
Eur J Med Chem; 2018 Oct; 158():68-81. PubMed ID: 30199706
[TBL] [Abstract][Full Text] [Related]
3. MEFAS, a hybrid of artesunate-mefloquine active against asexual stages of Plasmodium vivax in field isolates, inhibits malaria transmission.
Penna-Coutinho J; da Silva Araújo M; Campos Aguiar AC; Sá PM; Rios CT; Medeiros JF; Pereira DB; Boechat N; Krettli AU
Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():150-155. PubMed ID: 34637981
[TBL] [Abstract][Full Text] [Related]
4. Promising approach to reducing Malaria transmission by ivermectin: Sporontocidal effect against Plasmodium vivax in the South American vectors Anopheles aquasalis and Anopheles darlingi.
Pinilla YT; C P Lopes S; S Sampaio V; Andrade FS; Melo GC; Orfanó AS; Secundino NFC; Guerra MGVB; Lacerda MVG; Kobylinski KC; Escobedo-Vargas KS; López-Sifuentes VM; Stoops CA; Baldeviano GC; Tarning J; Vasquez GM; Pimenta PFP; Monteiro WM
PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006221. PubMed ID: 29444080
[TBL] [Abstract][Full Text] [Related]
5. A Novel Hybrid of Chloroquine and Primaquine Linked by Gold(I): Multitarget and Multiphase Antiplasmodial Agent.
de Souza Pereira C; Costa Quadros H; Magalhaes Moreira DR; Castro W; Santos De Deus Da Silva RI; Botelho Pereira Soares M; Fontinha D; Prudêncio M; Schmitz V; Dos Santos HF; Gendrot M; Fonta I; Mosnier J; Pradines B; Navarro M
ChemMedChem; 2021 Feb; 16(4):662-678. PubMed ID: 33231370
[TBL] [Abstract][Full Text] [Related]
6. Antimalarial efficacy of Pongamia pinnata (L) Pierre against Plasmodium falciparum (3D7 strain) and Plasmodium berghei (ANKA).
Satish PVV; Sunita K
BMC Complement Altern Med; 2017 Sep; 17(1):458. PubMed ID: 28893216
[TBL] [Abstract][Full Text] [Related]
7. A randomized feasibility trial comparing four antimalarial drug regimens to induce
Reuling IJ; van de Schans LA; Coffeng LE; Lanke K; Meerstein-Kessel L; Graumans W; van Gemert GJ; Teelen K; Siebelink-Stoter R; van de Vegte-Bolmer M; de Mast Q; van der Ven AJ; Ivinson K; Hermsen CC; de Vlas S; Bradley J; Collins KA; Ockenhouse CF; McCarthy J; Sauerwein RW; Bousema T
Elife; 2018 Feb; 7():. PubMed ID: 29482720
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling.
Le Bihan A; de Kanter R; Angulo-Barturen I; Binkert C; Boss C; Brun R; Brunner R; Buchmann S; Burrows J; Dechering KJ; Delves M; Ewerling S; Ferrer S; Fischli C; Gamo-Benito FJ; Gnädig NF; Heidmann B; Jiménez-Díaz MB; Leroy D; Martínez MS; Meyer S; Moehrle JJ; Ng CL; Noviyanti R; Ruecker A; Sanz LM; Sauerwein RW; Scheurer C; Schleiferboeck S; Sinden R; Snyder C; Straimer J; Wirjanata G; Marfurt J; Price RN; Weller T; Fischli W; Fidock DA; Clozel M; Wittlin S
PLoS Med; 2016 Oct; 13(10):e1002138. PubMed ID: 27701420
[TBL] [Abstract][Full Text] [Related]
9. A primaquine-chloroquine hybrid with dual activity against Plasmodium liver and blood stages.
Lödige M; Lewis MD; Paulsen ES; Esch HL; Pradel G; Lehmann L; Brun R; Bringmann G; Mueller AK
Int J Med Microbiol; 2013 Dec; 303(8):539-47. PubMed ID: 23992634
[TBL] [Abstract][Full Text] [Related]
10. A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites.
Bosson-Vanga H; Primas N; Franetich JF; Lavazec C; Gomez L; Ashraf K; Tefit M; Soulard V; Dereuddre-Bosquet N; Le Grand R; Donnette M; Mustière R; Amanzougaghene N; Tajeri S; Suzanne P; Malzert-Fréon A; Rault S; Vanelle P; Hutter S; Cohen A; Snounou G; Roques P; Azas N; Lagardère P; Lisowski V; Masurier N; Nguyen M; Paloque L; Benoit-Vical F; Verhaeghe P; Mazier D
Microbiol Spectr; 2021 Oct; 9(2):e0027421. PubMed ID: 34724729
[TBL] [Abstract][Full Text] [Related]
11. Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activity.
Vanaerschot M; Lucantoni L; Li T; Combrinck JM; Ruecker A; Kumar TRS; Rubiano K; Ferreira PE; Siciliano G; Gulati S; Henrich PP; Ng CL; Murithi JM; Corey VC; Duffy S; Lieberman OJ; Veiga MI; Sinden RE; Alano P; Delves MJ; Lee Sim K; Winzeler EA; Egan TJ; Hoffman SL; Avery VM; Fidock DA
Nat Microbiol; 2017 Oct; 2(10):1403-1414. PubMed ID: 28808258
[TBL] [Abstract][Full Text] [Related]
12. Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria.
Gogtay N; Kannan S; Thatte UM; Olliaro PL; Sinclair D
Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD008492. PubMed ID: 24163021
[TBL] [Abstract][Full Text] [Related]
13. Antimalarial and anti-inflammatory activities of new chloroquine and primaquine hybrids: Targeting the blockade of malaria parasite transmission.
Boechat N; Carvalho RCC; Ferreira MLG; Coutinho JP; Sa PM; Seito LN; Rosas EC; Krettli AU; Bastos MM; Pinheiro LCS
Bioorg Med Chem; 2020 Dec; 28(24):115832. PubMed ID: 33166927
[TBL] [Abstract][Full Text] [Related]
14. Antiplasmodial efficacy of
Satish PVV; Kumari DS; Sunita K
J Vector Borne Dis; 2017; 54(3):215-225. PubMed ID: 29097636
[TBL] [Abstract][Full Text] [Related]
15. Differential roles of an Anopheline midgut GPI-anchored protein in mediating Plasmodium falciparum and Plasmodium vivax ookinete invasion.
Mathias DK; Jardim JG; Parish LA; Armistead JS; Trinh HV; Kumpitak C; Sattabongkot J; Dinglasan RR
Infect Genet Evol; 2014 Dec; 28():635-47. PubMed ID: 24929123
[TBL] [Abstract][Full Text] [Related]
16. Optimally timing primaquine treatment to reduce Plasmodium falciparum transmission in low endemicity Thai-Myanmar border populations.
Lawpoolsri S; Klein EY; Singhasivanon P; Yimsamran S; Thanyavanich N; Maneeboonyang W; Hungerford LL; Maguire JH; Smith DL
Malar J; 2009 Jul; 8():159. PubMed ID: 19604346
[TBL] [Abstract][Full Text] [Related]
17. Development of Mitochondria Targeting AIE-Active Cyclometalated Iridium Complexes as Potent Antimalarial Agents.
Kumari G; Gupta A; Sah RK; Gautam A; Saini M; Gupta A; Kushawaha AK; Singh S; Sasmal PK
Adv Healthc Mater; 2023 Apr; 12(9):e2202411. PubMed ID: 36515128
[TBL] [Abstract][Full Text] [Related]
18. Primaquine for reducing Plasmodium falciparum transmission.
Graves PM; Gelband H; Garner P
Cochrane Database Syst Rev; 2012 Sep; (9):CD008152. PubMed ID: 22972117
[TBL] [Abstract][Full Text] [Related]
19. Novel 4-aminoquinoline analogs highly active against the blood and sexual stages of Plasmodium in vivo and in vitro.
Sáenz FE; Mutka T; Udenze K; Oduola AM; Kyle DE
Antimicrob Agents Chemother; 2012 Sep; 56(9):4685-92. PubMed ID: 22710117
[TBL] [Abstract][Full Text] [Related]
20. PFMDR1 POLYMORPHISMS INFLUENCE ON IN VITRO SENSITIVITY OF THAI PLASMODIUM FALCIPARUM ISOLATES TO PRIMAQUINE, SITAMAQUINE AND TAFENOQUINE.
Kaewpruk N; Tan-ariya P; Ward SA; Sitthichot N; Suwandittakul N; Mungthin M
Southeast Asian J Trop Med Public Health; 2016 May; 47(3):366-76. PubMed ID: 27405118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
